Abstract
Long noncoding RNA (lncRNA) FOXC2-AS1 has been reported to act as an oncogene in multiple human cancers. However, the clinical significance, functional role and underlying mechanism of FOXC2-AS1 in gastric cancer (GC) remains largely unknown. Here, we found that FOXC2-AS1 expression was significantly elevated in GC tissues and cells, and overexpression of FOXC2-AS1 indicated advanced TNM stage and shorter overall survival in GC patients. Functionally, knockdown of FOXC2-AS1 attenuated the proliferation, migration and invasion of GC cells, whereas overexpression of FOXC2-AS1 showed the opposite effects. Further investigation revealed that FOXC2-AS1 interacted with FOXC2 mRNA and repressed its degradation. FOXC2-AS1 recruited RNA methyltransferase NSUN2 to FOXC2 mRNA, increasing its m5C level and association with YBX1. Taken together, our findings suggested that FOXC2-AS1 acted as an oncogenic lncRNA by stabilizing FOXC2 mRNA in an m5C-dependent manner, which may provide a novel therapeutic target for GC.
Similar content being viewed by others
Data availability
The data used in this research are available.
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: Cancer J Clini. 2020;70(1):7–30. https://doi.org/10.3322/caac.21590.
Sukri A, Hanafiah A, Mohamad Zin N, Kosai NR. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis. APMIS : Acta Pathol Microbiol Immunol Scand. 2020;128(2):150–61. https://doi.org/10.1111/apm.13034.
Lim JH, Shin CM, Han KD, Lee SW, Jin EH, Choi YJ, et al. Association between the persistence of obesity and the risk of gastric cancer: a nationwide population-based study. Cancer Res Treat Official J Korean Cancer Assoc. 2021. https://doi.org/10.4143/crt.2021.130.
Oshi M, Satyananda V, Angarita FA, Kim TH, Tokumaru Y, Yan L, et al. Angiogenesis is associated with an attenuated tumor microenvironment, aggressive biology, and worse survival in gastric cancer patients. Am J Cancer Res. 2021;11(4):1659–71.
Grilli R, Violi F, Bassi MC, Marino M. The effects of centralizing cancer surgery on postoperative mortality: a systematic review and meta-analysis. J Health Services Res Policy. 2021. https://doi.org/10.1177/13558196211008942.
Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7. https://doi.org/10.1038/onc.2017.184.
Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, et al. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013;500(7464):598–602. https://doi.org/10.1038/nature12451.
Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–83. https://doi.org/10.1038/nrg.2016.20.
Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–63. https://doi.org/10.1016/j.ccell.2016.03.010.
Wang Z, Wang X, Zhang T, Su L, Liu B, Zhu Z, et al. LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation. Cell Death Dis. 2021;12(4):368. https://doi.org/10.1038/s41419-021-03645-4.
Shen H, Zhu H, Chen Y, Shen Z, Qiu W, Qian C, et al. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression. Cell Death Dis. 2021;12(4):349. https://doi.org/10.1038/s41419-021-03571-5.
Luo Y, Zheng S, Wu Q, Wu J, Zhou R, Wang C, et al. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy. 2021. https://doi.org/10.1080/15548627.2021.1901204.
Pan T, Yu Z, Jin Z, Wu X, Wu A, Hou J, et al. Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mole Therapy Nucleic Acids. 2021;23:1288–303. https://doi.org/10.1016/j.omtn.2021.02.003.
Zhang CL, Zhu KP, Ma XL. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 2017;396:66–75. https://doi.org/10.1016/j.canlet.2017.03.018.
Yang H, Chen T, Xu S, Zhang S, Zhang M. Long noncoding RNA FOXC2-AS1 predicts poor survival in breast cancer patients and promotes cell proliferation. Oncol Res. 2019;27(2):219–26. https://doi.org/10.3727/096504018X15213126075068.
Chen Y, Gu M, Liu C, Wan X, Shi Q, Chen Q, et al. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. Gene. 2019;686:37–42. https://doi.org/10.1016/j.gene.2018.10.085.
Sun Z, He C, Xiao M, Wei B, Zhu Y, Zhang G, et al. LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15. Am J Trans Res. 2019;11(7):4552–60.
Pan K, Xie Y. LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway. Cell Death Dis. 2020;11(6):434. https://doi.org/10.1038/s41419-020-2633-7.
Nombela P, Miguel-Lopez B, Blanco S. The role of m(6)A, m(5)C and Psi RNA modifications in cancer: Novel therapeutic opportunities. Mol Cancer. 2021;20(1):18. https://doi.org/10.1186/s12943-020-01263-w.
Chellamuthu A, Gray SG. The RNA methyltransferase NSUN2 and its potential roles in cancer. Cells. 2020. https://doi.org/10.3390/cells9081758.
Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2014;5(1):95–110. https://doi.org/10.1002/wrna.1200.
Xu DF, Tao XH, Yu Y, Teng Y, Huang YM, Ma JW, et al. LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2. Eur Rev Med Pharmacol Sci. 2020;24(17):8940–6. https://doi.org/10.26355/eurrev_202009_22835.
He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176. https://doi.org/10.1186/s12943-019-1109-9.
Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270–88. https://doi.org/10.1016/j.ccell.2020.02.004.
Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, et al. m(6)A Demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31(4):591-606. e6. https://doi.org/10.1016/j.ccell.2017.02.013.
Mei L, Shen C, Miao R, Wang JZ, Cao MD, Zhang YS, et al. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner. Cell Death Dis. 2020;11(4):270. https://doi.org/10.1038/s41419-020-2487-z.
Sun Z, Xue S, Zhang M, Xu H, Hu X, Chen S, et al. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39(45):6906–19. https://doi.org/10.1038/s41388-020-01475-w.
Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan X, et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21(8):978–90. https://doi.org/10.1038/s41556-019-0361-y.
Yang X, Yang Y, Sun BF, Chen YS, Xu JW, Lai WY, et al. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell Res. 2017;27(5):606–25. https://doi.org/10.1038/cr.2017.55.
Wu Y, Yamada S, Izumi H, Li Z, Shimajiri S, Wang KY, et al. Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer. J Surg Oncol. 2012;105(7):724–30. https://doi.org/10.1002/jso.23030.
Mo D, Fang H, Niu K, Liu J, Wu M, Li S, et al. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway. Can Res. 2016;76(10):3057–66. https://doi.org/10.1158/0008-5472.CAN-15-2361.
Huang S, Zhang X, Guan B, Sun P, Hong CT, Peng J, et al. A novel circular RNA hsa_circ_0008035 contributes to gastric cancer tumorigenesis through targeting the miR-375/YBX1 axis. Am J Trans Res. 2019;11(4):2455–62.
Xue X, Huang J, Yu K, Chen X, He Y, Qi D, et al. YB-1 transferred by gastric cancer exosomes promotes angiogenesis via enhancing the expression of angiogenic factors in vascular endothelial cells. BMC Cancer. 2020;20(1):996. https://doi.org/10.1186/s12885-020-07509-6.
Acknowledgements
Not applicable.
Funding
This study was supported by the Natural Science Foundation of Hanchuan (No. 2018–10-13-54HC).
Author information
Authors and Affiliations
Contributions
All experiments were carried out by all authors. JL designed this research and wrote the manuscript. All authors approved the submission of this manuscript.
Corresponding author
Ethics declarations
Conflict of interests
None.
Ethics approval
This work was approved by the Ethics Committee of Hanchuan People’s Hospital in accordance with the Declaration of Helsinki (approval number: 2020-05-01-143GP).
Informed consent
Written informed consent was obtained from all patients.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yan, J., Liu, J., Huang, Z. et al. FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells. Human Cell 34, 1755–1764 (2021). https://doi.org/10.1007/s13577-021-00583-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-021-00583-3